• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Serious Infectious Complications After Rituximab Therapy in Patients With Autoimmunity: Is This the Final Word?

作者信息

Gkrania-Klotsas Effrossyni, Kumararatne Dinakantha S

机构信息

Department of Infectious Diseases, Cambridge University Hospitals, Cambridge, United Kingdom.

Department of Clinical Immunology, Cambridge University Hospitals, Cambridge, United Kingdom.

出版信息

Clin Infect Dis. 2021 Mar 1;72(5):738-742. doi: 10.1093/cid/ciaa131.

DOI:10.1093/cid/ciaa131
PMID:32067045
Abstract
摘要

相似文献

1
Serious Infectious Complications After Rituximab Therapy in Patients With Autoimmunity: Is This the Final Word?自身免疫性疾病患者接受利妥昔单抗治疗后的严重感染并发症：这是最终定论吗？
Clin Infect Dis. 2021 Mar 1;72(5):738-742. doi: 10.1093/cid/ciaa131.
2
Rituximab hypersensitivity in IgG4-related disease: successful desensitization in a patient with IgG4 rheumatoid factor.IgG4相关疾病中的利妥昔单抗超敏反应：1例伴有IgG4类风湿因子患者的成功脱敏治疗
Int J Rheum Dis. 2017 Feb;20(2):276-279. doi: 10.1111/1756-185X.13021. Epub 2016 Dec 30.
3
Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin.利妥昔单抗与静脉注射免疫球蛋白联合逆转自身免疫
Front Immunol. 2018 Jul 18;9:1189. doi: 10.3389/fimmu.2018.01189. eCollection 2018.
4
Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease: a case series.免疫球蛋白 G 替代治疗用于治疗自身免疫性疾病相关利妥昔单抗相关性低丙种球蛋白血症感染并发症：病例系列研究。
J Autoimmun. 2015 Feb;57:24-9. doi: 10.1016/j.jaut.2014.11.004. Epub 2015 Jan 10.
5
Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseases.利妥昔单抗治疗儿童难治性自身免疫性疾病的临床疗效及安全性
J Pediatr. 2007 Apr;150(4):376-82. doi: 10.1016/j.jpeds.2006.10.067.
6
Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases.利妥昔单抗相关低丙种球蛋白血症与儿科自身免疫性疾病。
Pediatr Rheumatol Online J. 2019 Aug 28;17(1):61. doi: 10.1186/s12969-019-0365-y.
7
[Late-onset neutropenia after rituximab therapy in patients with autoimmune thrombotic and hemostatic disorders: a single center analysis].[利妥昔单抗治疗自身免疫性血栓形成和止血障碍患者后的迟发性中性粒细胞减少症：单中心分析]
Rinsho Ketsueki. 2017;58(1):42-46. doi: 10.11406/rinketsu.58.42.
8
Serious Infectious Events and Immunoglobulin Replacement Therapy in Patients With Autoimmune Disease Receiving Rituximab: A Retrospective Cohort Study.接受利妥昔单抗治疗的自身免疫性疾病患者的严重感染事件和免疫球蛋白替代治疗：一项回顾性队列研究。
Clin Infect Dis. 2021 Mar 1;72(5):727-737. doi: 10.1093/cid/ciaa127.
9
Fetal outcomes after rituximab exposure in women with autoimmune vasculitis.自身免疫性血管炎女性使用利妥昔单抗后的胎儿结局。
Ann Rheum Dis. 2013 Dec;72(12):2051-3. doi: 10.1136/annrheumdis-2013-203833. Epub 2013 Jul 17.
10
Pneumocystis jirovecii pneumonia in patients treated with rituximab for systemic diseases: Report of 11 cases and review of the literature.利妥昔单抗治疗全身性疾病患者的耶氏肺孢子菌肺炎：11例报告及文献复习
Eur J Intern Med. 2018 Apr;50:e23-e24. doi: 10.1016/j.ejim.2017.11.014. Epub 2017 Dec 1.

引用本文的文献

1
Influencing Factors of Treatment Response to Rituximab in Refractory Membranous Nephropathy.利妥昔单抗治疗难治性膜性肾病疗效的影响因素
Drug Des Devel Ther. 2025 Aug 18;19:7059-7067. doi: 10.2147/DDDT.S538971. eCollection 2025.
2
IgG4-related disease - focus on digestive system involvement.IgG4相关性疾病——聚焦于消化系统受累情况。
Front Immunol. 2025 Jun 18;16:1584107. doi: 10.3389/fimmu.2025.1584107. eCollection 2025.
3
Efficacy and safety of rituximab in anti-MuSK myasthenia Gravis: a systematic review and meta-analysis.
利妥昔单抗治疗抗MuSK型重症肌无力的疗效与安全性：一项系统评价和荟萃分析
Sci Rep. 2025 Feb 28;15(1):7219. doi: 10.1038/s41598-025-90937-w.
4
Advances in Multitarget Therapeutic Approaches for Immune-Mediated Glomerular Diseases.免疫介导性肾小球疾病多靶点治疗方法的进展
Life (Basel). 2025 Feb 6;15(2):243. doi: 10.3390/life15020243.
5
Use of tafenoquine to treat a patient with relapsing babesiosis with clinical and molecular evidence of resistance to azithromycin and atovaquone.使用他非诺喹治疗一名患有复发性巴贝斯虫病的患者，该患者具有对阿奇霉素和阿托伐醌耐药的临床及分子证据。
IDCases. 2022 Feb 25;27:e01460. doi: 10.1016/j.idcr.2022.e01460. eCollection 2022.
6
Mechanism of Action and Efficacy of Immunosupressors in Lupus Nephritis.免疫抑制剂在狼疮性肾炎中的作用机制及疗效
Int J Nephrol Renovasc Dis. 2021 Dec 11;14:441-458. doi: 10.2147/IJNRD.S335371. eCollection 2021.
7
Peripheral B Cell Deficiency and Predisposition to Viral Infections: The Paradigm of Immune Deficiencies.外周 B 细胞缺陷与病毒感染易感性：免疫缺陷的范例。
Front Immunol. 2021 Aug 30;12:731643. doi: 10.3389/fimmu.2021.731643. eCollection 2021.